Posted Sep. 24, 2015 at 10:29 AM
Updated Sep 24, 2015 at 12:04 PM
Faina Shtern, president and CEO of the AdMeTech Foundation, will host a workshop on ending prostate cancer from 2 to 3 p.m. Sept. 26 at the DoubleTree Boston Bedford Hotel, 44 Middlesex Turnpike. This event is in honor of National Prostate Cancer Awareness Month and is focused on ending prostate cancer as a health care disparity in black men in Massachusetts. The event will be held during the annual meeting for the New England Area Conference, National Association for the Advancement of Colored People.
The goal of the event is to inform and mobilize NEAC NAACP delegates in the fight against the disproportionate risk and death toll of prostate cancer in black men. Prostate cancer is the most common malignancy in Massachusetts, with 60 percent higher incidence in black men. Although prostate cancer is curable when detected early, black men have 2.5 times higher mortality than the national and state averages for all races. This disparity in mortality of prostate cancer is greater than of any other malignancies, cardiovascular diseases, hypertension or obesity.
During the workshop, Dr. Shtern will lead a discussion on the integration of precision screening and diagnosis with minimally invasive treatment. She will be joined by Dr. Jason A. Efstathiou, MD, DPhil., Associate Professor and Director of Genitourinary Division, Department of Radiation Oncology at the Massachusetts General Hospital, Harvard Medical School. He also serves as a board member of the Massachusetts Prostate Cancer Coalition.
This event is part of AdMeTech’s joint state-wide campaign with NEAC NAACP and MPCC to bring advances in prostate cancer care to every man, with the focus on the individuals at high risk, their caregivers and doctors. AdMeTech’s mission is to create a Massachusetts model of national leadership in prostate cancer care, research and awareness.